The considerable fraction of 44.7 % heterogeneously ERG positive cancer foci and the continuous increase of ERG positive areas with tumor focus size found in our study further suggests that ERG fusion may not always be an initiating event but can also occur later during prostate cancer evolution. The gene discussed is ERG; the disease is neoplasm.